The Glycaemic Effect of Isomaltulose Consumption in Healthy Participants
Launched by SINGAPORE INSTITUTE OF FOOD AND BIOTECHNOLOGY INNOVATION · Jan 11, 2017
Trial Information
Current as of June 18, 2025
Completed
Keywords
ClinConnect Summary
The objective of the present study is to investigate the glycaemic effect of isomaltulose in Chinese, Indians, Malays and Caucasians. This will be a single intervention. Up to fifty participants, consisting of at least ten Chinese, ten Malays, ten Indians, and ten Caucasians completed data sets, aged between 21 and 40 years will be recruited from the general public in Singapore. Participants will be asked to attend two test sessions for this study. Participants will consume either a sucrose drink or an isomaltulose drink (each containing 50 g of available carbohydrate).
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chinese, Indian, Malay or Caucasian ethnic origin
- Exclusion Criteria:
- • People with major chronic disease such as heart disease, cancer or diabetes mellitus
- • Individuals with food intolerances or allergies to isomaltulose or sucrose
- • Individuals who are taking insulin or drugs known to affect glucose metabolism and body fat distribution
- • People with a major medical or surgical event requiring hospitalization within the preceding 3 months
- • Individuals with the presence of disease or drugs which influence digestion and absorption of nutrients
- • Pregnant women
About Singapore Institute Of Food And Biotechnology Innovation
The Singapore Institute of Food and Biotechnology Innovation (SIFBI) is a leading research organization dedicated to advancing the fields of food science and biotechnology. As a prominent sponsor of clinical trials, SIFBI focuses on innovative solutions that enhance food safety, quality, and sustainability, leveraging cutting-edge technologies to address global challenges in nutrition and health. With a multidisciplinary team of experts, SIFBI collaborates with industry partners and academic institutions to translate research findings into practical applications, fostering the development of functional foods and bio-based products that promote well-being and improve public health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Melvin Leow, MD
Principal Investigator
Clinical Nutrition Research Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials